Developing an Item Bank to Measure Quality of Life in Individuals With Glaucoma, and the Results of the Interview With Patients: The Effect of Visual Function, Visual Field Progression Rate, Medical, and Surgical Treatments on Quality of Life

Glaucoma and Ocular PressureOcular Oncology

Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression

J Glaucoma.

Liebmann K, De Moraes CG, Liebmann JM

doi: 10.1097/IJG.

Glaucoma and Ocular PressureOcular Oncology

Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist

JAMA Ophthalmol.

Musch DC, Tarver ME, Goren MJ, Janz NK

doi: 10.1001/

Glaucoma and Ocular PressureOcular Oncology

Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma

JAMA Ophthalmol.

Blumberg DM, De Moraes CG, Prager AJ, Yu Q, Al-Aswad L, Cioffi GA, Liebmann JM, Hood DC

doi: 10.1001/

Glaucoma and Ocular PressureOcular Oncology

Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life

JAMA Ophthalmol.

Prager AJ, Hood DC, Liebmann JM, De Moraes CG, Al-Aswad LA, Yu Q, Cioffi GA, Blumberg DM

doi: 10.1001/jamaophthalmol.

Glaucoma and Ocular PressureOcular Oncology

Binocular Measures of Visual Acuity and Visual Field versus Binocular Approximations

Ophthalmology.

Musch DC, Niziol LM, Gillespie BW, Lichter PR, Janz NK

doi: 10.1016/j.ophtha.2017.02.013.

Glaucoma and Ocular PressureOcular Oncology

Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma

J Glaucoma.

Muratov S, Podbielski DW, Kennedy K, Jack SM, Pemberton J, Ahmed IIK, Baltaziak M, Xie F

doi: 10.1097/

Glaucoma and Ocular PressureRetinal Diseases

Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?

J Glaucoma.

Schrems WA, Schrems-Hoesl LM, Mardin CY, Laemmer R, Kruse FE, Horn FK

doi: 10.1097/

Uveitis

Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials

JAMA Ophthalmol.

Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N, Skup M, Dick AD

RECOMMENDED

Glaucoma and Ocular Pressure

Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

doi: 10.1001/jamaophthalmol.2020.0647.

Related content

Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression

Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist

Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma

Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life

Binocular Measures of Visual Acuity and Visual Field versus Binocular Approximations

Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma

Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?

Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials

Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma